Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
3-Mercaptopyruvate sulfurtransferase (MPST) is a cytoplasmic enzyme (EC 2.8.1.2) belonging to the rhodanese family of sulfurtransferases, catalyzing the transfer of sulfane sulfur from 3-mercaptopyruvate to acceptors like cyanide or thiols, forming pyruvate and products such as thiocyanate or hydrogen sulfide (H2S). It operates via a double-displacement mechanism involving a catalytic cysteine persulfide intermediate (Cys247 in humans), supported by a Ser-His-Asp triad, and contributes to cysteine degradation, tRNA thiolation, protein urmylation, and cyanide detoxification. MPST is broadly expressed in tissues including liver, kidney, heart, brain, and vasculature, where it generates H2S to modulate nitric oxide signaling and promote vasodilation. Dysregulation links it to oxidative stress resistance, mitochondrial function, fatty acid metabolism, and aging-related changes. In disease, elevated MPST correlates with bladder cancer progression, serving as a potential biomarker, while deficiency causes mercaptolactate-cysteine disulfiduria (Ampola syndrome) with neurological symptoms; it also influences intestinal apoptosis and metabolic disorders. Though not a primary drug target, selective inhibitors targeting its persulfide site have been characterized for H2S modulation research.
Inhibition of persulfide formation at catalytic cysteine (Cys247/Cys253); Double displacement via enzyme-bound persulfide intermediate
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-mercaptopyruvate sulfurtransferase (MPST).